Medindia

X

Ranbaxy Ties Up With US Co For Mktg Zonisamide Capsules

by Medindia Content Team on  June 9, 2006 at 5:50 PM Drug News   - G J E 4
Ranbaxy Ties Up With US Co For Mktg Zonisamide Capsules
Pharma major Ranbaxy Laboratories Ltd has entered into a strategic partnership with US-based Invagen Pharmaceuticals Inc for marketing Zonisamide Capsules , which are used for the treatment of epilepsy, in the US market.
Advertisement

Under the agreement products would be developed and submitted for approval to the USFDA. Ranbaxy Pharmaceuticals Inc would market the products under the the company's label.

Advertisement
Zonisamide Capsules, which are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy, have total annualized sales of 170.30 million dollars, Ranbaxy informed the Stock Exchanges.

'Such partnerships with companies like Invagen, who have capabilities and competencies to develop bioequivalent generic product for the marketplace, are naturally beneficial to both organizations while having a positive economic impact on the US healthcare system,' Ranbaxy Inc President Atul Malhotra said.

(Source:PTI News)
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: